Dr Reddy's Laboratories Stock News

Dr Reddy''s Laboratories has entered into an exclusive sales and distribution agreement with Novartis India Ltd (NIL), a statement said

Stocks to watch: A 0.7 percent fall in SGX-traded Nifty50 to 17,476.5 hinted at investors taking some money off the table on Friday. Key stocks to watch out for in today''s trading session are Hero MotoCorp, Dr Reddy''s, Zomato, Tata Chemicals and Trent. Here is a list of today''s stocks to watch:

Stocks in focus: Aurobindo Pharma, Dr Reddy''s Labs, Tata Steel and more

Dr Reddy''s Laboratories on Wednesday said it has launched a vasopressin injection, which is used to control frequent urination, increased thirst, and loss of water caused by diabetes, in the American…

Dr Reddy''s Laboratories said it has launched vasopressin injection, which is used to control frequent urination, increased thirst, and loss of water caused by diabetes, in the American market.

Dr Reddy''s Laboratories, marketing partner of the Russian Direct Investment Fund for the Sputnik V and Sputnik Light vaccines, has sought government approval for use of Sputnik Light as a booster shot

Mumbai, February 8 Equity benchmark Sensex surged over 150 points in opening trade on Tuesday, tracking gains in index majors Maruti, Titan and Bajaj Finserv amid a mixed trend in global markets. Starting on a positive note, the BSE gauge was trading 156.46 points or 0.27 per cent higher at 57,777.65 in early trade. The Nifty surged 48.75 points or 0.28 per cent to 17,262.35. Maruti was the top gainer in the Sensex pack, climbing 1.83 per cent, followed by Titan, Bajaj Finserv, Bajaj Finance, Dr Reddy''s, Tata Steel and Asian Paints. On the other hand, PowerGrid, TCS, SBI, NTPC and Infosys were among the losers. In the previous session, the 30-share index ended 1,023.63 points or 1.75 per cent lower at 57,621.19. Similarly, the NSE Nifty slumped 302.70 points or 1.73 per cent to 17,213.60. Elsewhere in Asia, bourses in Hong Kong and Shanghai were trading with losses in mid-session deals, while Seoul and Tokyo were in the green. Stock exchanges in the US closed on a mixed note in the overnight session.

New Delhi: The single-dose Russian-origin Sputnik-Light vaccine has been approved for emergency use by the Indian pharma regulator, offering medics with yet another vaccination to combat the Covid-19 pandemic, which has claimed the lives of over five lakh Indians in the last two years. "In India, the Drugs Controller General has approved single-dose Sputnik Light Covid-19 vaccination emergency use approval. This is the country''s ninth Covid-19 vaccination. On Sunday, Union Health Minister Mansukh Mandaviya tweeted, "This will further boost the nation''s joint struggle against the pandemic." The single-dose Russian-origin Sputnik-Light vaccine has been certified for emergency use by the Indian pharma regulator, offering medics with yet another vaccination to combat the Covid-19 pandemic, which has claimed the lives of over five lakh Indians in the last two years. "In India, the Drugs Controller General has approved single-dose Sputnik Light Covid-19 vaccination emergency use approval. This is the country''s ninth Covid-19 vaccination.

Equity benchmark Sensex fell 225 points in opening trade on Monday, tracking losses in index majors HDFC twins, Infosys and Maruti amid persistent foreign

The week will see investors reacting to the RBI policy outcome on Thursday, its commentary on inflation, IIP reading, quarterly earnings and trends in the bond market.

Dr Reddy''s Laboratories jumped 5.74% to Rs 4,600 after the company announced that the Drugs Controller General of India (DCGI) has granted approval to the single-shot Sputnik Light vaccine for restricted use in emergency situation in India.

Dr Reddy''s Laboratories jumped 5.74% to Rs 4,600 after the company announced that the Drugs Controller General of India (DCGI) has granted approval to the single-shot Sputnik Light vaccine for restricted use in emergency situation in India.

Drug major Dr Reddy''s Laboratories has submitted a proposal to the Drugs Controller General of India (DCGI) to register Sputnik Light vaccine as a booster dose against COVID-19, a top company official

"As regards to Sputnik, we are now ready with capacities in India. We are working actively with the Government of India for registering Sputnik Light as a vaccine and as a booster dose of Sputnik V," Dr Reddy''s Laboratories CEO Erez Israeli said in an analyst call.

India News: NEW DELHI: Drug major Dr Reddy''s Laboratories has submitted a proposal to the Drugs Controller General of India (DCGI) to register Sputnik Light vacci.